Mystic Asset Management, Inc. Supernus Pharmaceuticals, Inc. Transaction History
Mystic Asset Management, Inc.
- $261 Million
- Q3 2024
A detailed history of Mystic Asset Management, Inc. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Mystic Asset Management, Inc. holds 28,240 shares of SUPN stock, worth $1.02 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
28,240
Previous 27,940
1.07%
Holding current value
$1.02 Million
Previous $747,000
17.8%
% of portfolio
0.34%
Previous 0.3%
Shares
11 transactions
Others Institutions Holding SUPN
# of Institutions
281Shares Held
60.6MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$377 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$222 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$185 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$105 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$95.5 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.94B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...